Black Diamond Therapeutics annual capital expenditures (capex)
2018
2019
2020
2021
2022
2023
2024
Black Diamond Therapeutics Capital Expenditures (CapEx) Growth & History (BDTX)
Black Diamond Therapeutics's capital expenditures (capex) was $0 for fiscal 2024.
View full Black Diamond Therapeutics company overviewBlack Diamond Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $0 | −$33,000 | — |
| 2023 | 2023-12-31 | $33,000 | −$159,000 | −82.81% |
| 2022 | 2022-12-31 | $192,000 | −$2.5M | −92.92% |
| 2021 | 2021-12-31 | $2.7M | $2.6M | +1808.45% |
| 2020 | 2020-12-31 | $142,000 | $121,000 | +576.19% |
| 2019 | 2019-12-31 | $21,000 | −$55,000 | −72.37% |
| 2018 | 2018-12-31 | $76,000 | — | — |
Black Diamond Therapeutics quarterly capital expenditures (capex)
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $33,000 | $25,000 | +312.50% |
| Q2 2023 | 2023-06-30 | $0 | −$193,000 | — |
| Q1 2023 | 2023-03-31 | $0 | −$7,000 | — |
| Q4 2022 | 2022-12-31 | $0 | −$333,000 | — |
| Q3 2022 | 2022-09-30 | $8,000 | −$1.5M | −99.46% |
| Q2 2022 | 2022-06-30 | $193,000 | −$655,000 | −77.24% |
| Q1 2022 | 2022-03-31 | $7,000 | −$33,000 | −82.50% |
| Q4 2021 | 2021-12-31 | $333,000 | $224,000 | +205.50% |
| Q3 2021 | 2021-09-30 | $1.5M | $1.5M | +18512.50% |
| Q2 2021 | 2021-06-30 | $848,000 | $823,000 | +3292.00% |
| Q1 2021 | 2021-03-31 | $40,000 | $40,000 | — |
| Q4 2020 | 2020-12-31 | $109,000 | $107,000 | +5350.00% |
| Q3 2020 | 2020-09-30 | $8,000 | −$3,000 | −27.27% |
| Q2 2020 | 2020-06-30 | $25,000 | $23,000 | +1150.00% |
| Q1 2020 | 2020-03-31 | $0 | −$10,000 | — |
| Q4 2019 | 2019-12-31 | $2,000 | — | — |
| Q3 2019 | 2019-09-30 | $11,000 | — | — |
| Q2 2019 | 2019-06-30 | $2,000 | — | — |
| Q1 2019 | 2019-03-31 | $10,000 | — | — |
Black Diamond Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Black Diamond Therapeutics's capital expenditures (capex) decreased from $21,000 to $0, a change of −$21,000. The latest reported quarter, Q4 2023, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Black Diamond Therapeutics source filings ↗